Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Complete versus saline crossover study in adults with dry eye
ACTRN12619000275167Phase 4Completed
- Sponsor
- University of New South Wales
- Start
- Apr 2019
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propylene glycol-hydroxypropyl guar nanoemulsion and saline in dry eye syndrome (DED) (2 arms), sponsored by University of New South Wales. Primary endpoint: Non-invasive tear break-up time. Started Apr 2019; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsionsaline
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ACTRN12619000275167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000275167.